Clinical Trials

42 enrolled

Prostatic Neoplasms

NCT06171139 2026-04-16

Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer

80 enrolled

Prostatic Neoplasms

NCT06347705 2026-04-16

A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer

57 enrolled

Prostatic Neoplasms

NCT06439225 2026-04-16

OPTION-DDR

236 enrolled

Prostatic Neoplasms

NCT06451614 2026-04-16

HYDROSPACE

230 enrolled

Prostatic Neoplasms

NCT06780670 2026-04-16

PSMAcTION

Phase 2/3 Recruiting

443 enrolled

Prostatic Neoplasms

NCT07213674 2026-04-16

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

750 enrolled

Prostatic Neoplasms

NCT03821792 2026-04-15

Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer

60 enrolled

BreastGastrointestinalGenitourinaryGynecologicLymphoid

Prostatic Neoplasms

NCT03935282 2026-04-15

AH-HA

Phase NA Completed

645 enrolled 43 charts

Breast Neoplasms, Cardiovascular Diseases, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Health Behavior, Endometrial Neoplasms

NCT04215029 2026-04-15

Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans

6 enrolled

Prostatic Neoplasms

NCT04396808 2026-04-15

Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer

805 enrolled

Prostatic Neoplasms

NCT04693377 2026-04-15

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

DermatologicGastrointestinalGenitourinaryHead & NeckSarcoma

40 enrolled

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Melanoma, Neoplasm Metastasis, Prostatic Neoplasms, Sarcoma, Thyroid Neoplasms, Colorectal Neoplasms

NCT04905069 2026-04-15

SABRE

500 enrolled

Phase EARLY_PHASE1 Active not recruiting

Neoplasms, Prostatic Neoplasms

NCT05047965 2026-04-15

An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate Cancer

65 enrolled

Prostatic Neoplasms

NCT05055843 2026-04-15

Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer

33 enrolled

Prostatic Neoplasms

NCT06136650 2026-04-15

MK-5684-004

1,314 enrolled

Prostatic Neoplasms

NCT06161506 2026-04-15

Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer

41 enrolled

Prostatic Hyperplasia, Prostatic Neoplasms, Urinary Incontinence, Urinary Incontinence, Stress, Urinary Incontinence, Urge

NCT06511141 2026-04-15

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

150 enrolled

Prostatic Hyperplasia, Prostatic Neoplasms, Urinary Bladder, Overactive

NCT06615752 2026-04-15

Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients

Phase 1/2 Recruiting

99 enrolled

Prostatic Neoplasms

NCT07002320 2026-04-15

ASpiRE

Phase 1/2 Recruiting

78 enrolled

Prostatic Neoplasms

NCT07111507 2026-04-15

A Study of Tarlatamab for People With Prostate Cancer

32 enrolled

Phase 1 Active not recruiting

Prostatic Neoplasms

NCT07236112 2026-04-15

Study of TRDC002 in the Diagnosis of Patients With PSMA-positive Prostate Cancer

6 enrolled

Prostatic Neoplasms

NCT07237269 2026-04-15

Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer

140 enrolled

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07475533 2026-04-15

Low-flow Versus Minimal-flow Sevoflurane Anesthesia During Robot-assisted Laparoscopic Radical Prostatectomy

70 enrolled

Prostatic Neoplasms

NCT01902680 2026-04-14

CURIEFOCALE

Phase 2 Completed

18 enrolled

Prostatic Neoplasms

NCT05487846 2026-04-14

Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation

120 enrolled

Prostatic Neoplasms

NCT05828082 2026-04-14

Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer

20 enrolled

Prostatic Neoplasms

NCT05847166 2026-04-14

A Phase 2/3,PSMA-T4, Prostate Cancer

80 enrolled

Prostatic Neoplasms

NCT05960578 2026-04-14

Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study

8 enrolled

Prostatic Neoplasms

NCT06122584 2026-04-14

Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer

380 enrolled

Prostatic Neoplasms

NCT06235697 2026-04-14

ASCENDE-SBRT

710 enrolled

Prostatic Neoplasms

NCT06592924 2026-04-14

TRIPLE-SWITCH

830 enrolled

Phase NA Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT07225309 2026-04-14

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

300 enrolled

BreastGastrointestinalGenitourinaryHead & Neck

Breast Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms

NCT07529717 2026-04-14

CRIUS-1

Phase 1/2 Not yet recruiting

42 enrolled

Phase 1 Active not recruiting

Prostatic Neoplasms

NCT01480154 2026-04-13

Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer

62 enrolled

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma, Prostatic Neoplasms

NCT01946204 2026-04-13

SPARTAN

Phase 3 Active not recruiting

1,207 enrolled 15 charts 2 FDA

Prostatic Neoplasms

NCT01982786 2026-04-13

Feasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate Cancer

Phase NA Completed

57 enrolled 16 charts

Phase 1 Active not recruiting

Prostatic Neoplasms

NCT02123758 2026-04-13

A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer

57 enrolled

Prostatic Neoplasms

NCT02225704 2026-04-13

Radium-223 in Combination With Enzalutamide

Phase 2 Completed

45 enrolled

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT02257736 2026-04-13

An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)

982 enrolled 15 charts

Prostatic Neoplasms

NCT02346253 2026-04-13

High-Dose Brachytherapy in Treating Patients With Prostate Cancer

146 enrolled

Prostatic Neoplasms

NCT02465060 2026-04-13

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)